Page last updated: 2024-10-22

acetazolamide and Paraproteinemias

acetazolamide has been researched along with Paraproteinemias in 1 studies

Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)

Paraproteinemias: A group of related diseases characterized by an unbalanced or disproportionate proliferation of immunoglobulin-producing cells, usually from a single clone. These cells frequently secrete a structurally homogeneous immunoglobulin (M-component) and/or an abnormal immunoglobulin.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leys, A1
Vandenberghe, P1

Other Studies

1 other study available for acetazolamide and Paraproteinemias

ArticleYear
Serous macular detachments in a patient with IgM paraproteinemia: an optical coherence tomography study.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2001, Volume: 119, Issue:6

    Topics: Acetazolamide; Aged; Diabetes Mellitus, Type 2; Diagnostic Techniques, Ophthalmological; Fluorescein

2001